News Releases

Date	Title
May 13, 2021	Homology Medicines Announces Presentations on its Expanding Genetic Medicines Platform and Internal GMP Manufacturing at the American Society of Gene & Cell Therapy Annual Meeting
May 06, 2021	Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights
May 03, 2021	Homology Medicines Presents Data Demonstrating In Vivo Transduction of Non-Human Primate and Human Retinal Cells at ARVO Annual Meeting
Apr 28, 2021	Homology Medicines Announces New Approach to Leverage AAVHSC Platform by Delivering One-Time In Vivo Gene Therapy to Produce Antibodies in Humanized Murine Model
Apr 14, 2021	Homology Medicines Announces Presentations at ACMG Annual Clinical Genetics Meeting
Apr 12, 2021	Homology Medicines Announces Promotion of Tim Kelly to Chief Operating Officer
Apr 07, 2021	Homology Medicines Announces Pricing of Public Offering of Common Stock
Apr 06, 2021	Homology Medicines Announces Proposed Public Offering of Common Stock
Mar 11, 2021	Homology Medicines Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
Mar 01, 2021	Homology Medicines Regains Worldwide Rights to Ophthalmology Program Based on its In Vivo Nuclease-Free Gene Editing Platform